At present there is relatively little information concerning the type-specific aspects of immunity to group A streptococcal infections in man. It has been demonstrated that an individual may suffer several different group A streptococcal infections within a single year. Although relatively few patients have been followed over long periods of time with adequate bacteriological studies, we do not know of a single instance in which it has been shown that the same patient suffered more than one nasopharyngeal infection with the same type of streptococcus. It is also now well known that the great majority of late purulent complications (1-5), and invariably the relapses and intercurrent sore throats
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(Received for publication, April 25, 1946) At present there is relatively little information concerning the type-specific aspects of immunity to group A streptococcal infections in man. It has been demonstrated that an individual may suffer several different group A streptococcal infections within a single year. Although relatively few patients have been followed over long periods of time with adequate bacteriological studies, we do not know of a single instance in which it has been shown that the same patient suffered more than one nasopharyngeal infection with the same type of streptococcus. It is also now well known that the great majority of late purulent complications (1) (2) (3) (4) (5) , and invariably the relapses and intercurrent sore throats (1) (2) (3) 6 ) occurring in patients with scarlet fever, are due to streptococci of a different type from that which caused the patient's original scarlatinal infection.
On the other hand, it is generally believed, although direct proof is usually lacking, that patients may suffer autogenous reinfections of other parts of the body with the same types of streptococci they are carrying in their respiratory tracts. Puerperal sepsis (7) (8) (9) (10) , wound infections (11) , erysipelas (12) (13) (14) , and paronychia (15) are examples of such reinfections. Some of these individuals, however, may have been healthy carriers; but in many instances they undoubtedly had previously suffered nasopharyngeal infections with these same types; particularly is this true in facial erysipelas where commonly there is a history of preceding sore throat or upper respiratory tract infection.
Practically all laboratory experiments dealing with immunity to and protection against group A streptococci have been done with small animals, usually * This article has been released for publication by the Division of Publications of the Bureau of Medicine and Surgery of the U. S. Navy. The opinions and views set forth in this article are those of the writers and are not to be considered as reflecting the policies of the Navy Department.
mice, which are unnatural hosts for this group of microorganisms; and highly artificial measures have been used to induce infections. From these experiments, however, it has been conclusively demonstrated that both passive and active immunity are type-specific; that is, the immunity is correlated with the antibody directed toward the type-specific M protein (16) (17) (18) .
I n contrast to the smaller laboratory animals, it is known that monkeys may harbor group A streptococci in their nasopharynges (19, 20) and occasionally may suffer spontaneous infections (21) with this group of microorganisms. I n this respect monkeys appear to approximate m a n in their host relationship with respect to group A streptococci; hence, it seems probable that a study of imm u n i t y to nasopharyngeal infections in monkeys might shed more light on the same problem in h u m a n beings. The following report deals with such observations.
Methods of Study
Thirteen young male and female Macaca mulalta weighing between 2180 and 3720 gm. were used. All were healthy with negative tuberculin tests and normal chest x-rays at the beginning of the study, and all remained well while under observation. The monkeys were housed singly or in pairs in small cages in two well ventilated rooms. Only animals inoculated with the same strain of streptococci were put in cages together. No cross or spontaneous streptococcal infections were observed.
Twelve different strains of group A streptococci representing 6 different types of varying antigenic composition were employed for the inoculations. Four strains (1RS85, 5RS101, 11RS50, and 1RSC150) had been recently isolated from patients with nasopharyngeal infections which preceded attacks of rheumatic fever. The remaining 8, chosen because of their known antigenic composition, were from stock cultures which had been preserved in the dried state. The type, antigenic composition, and source of each strain are given in Table I .
Eighteen hour cultures grown in modified Todd-Hewitt broth (23) and resuspended in equal volumes of saline were used for inoculation. One and a half cc. of the freshly prepared saline suspension was dropped into each nostril of a monkey under deep ether anesthesia. The inocula contained between 70 and 450 million microorganisms per co.
The following data were collected from all of the animals at weekly intervals for at least 8 weeks following each inoculation: nose and throat cultures made in duplicate on rabbit and sheep blood agar plates; leucocyte counts; erythrocyte sedimentation rates; antifibrinolysin and antistreptolysin O determinations. On the sera from a limited number of animals agglufinin and bacteriostatic tests also were made. The blood agar plates were incubated for 18 hours at 37°C.; and representative colonies of all hemolytic streptococci were then picked to broth for grouping and typing according to the method of Lancefield (24) and Swift, Wilson, and Lancefield (25) . Antistreptolysin O determinations were made according to the method of Todd (26) and modified as previously described (27) ; the antifibrinolysin determinations were made according to the method described by Tillett, Edwards, and Garner (28) and Boisvert (29) . The Westergren method (30), with tubes 1.5 by 200 ram., was used to determine the erythrocyte sedimentation rate.
The agglutinin tests were done according to the technique described by Lancefield (18) . Bacterial suspensions were prepared from cultures grown in modified Todd-Hewitt broth at room temperature for 12 to 18 hours. The bacteria were separated by centrifugation and resuspended in the desired concentration in fresh broth. These suspensions were added in volumes of 0.5 cc. to equal volumes of progressive twofold serum dilutions in broth. Readings Scarlet fever followed by rheumatic fever, Rockefeller Hospital * NC = not classified. ~: Strains 11RS50 and 24RS50G contain a common agglutinogen which is neither the M or T antigen. 11RS50 was obtained from a patient with acute pharyngitis followed by an attack of rheumatic fever. 24RS$0G was isolated from same patient 4~ months later during convalescence from attack of rheumatic fever. Strain 24RSSOG recovered the capacity to produce the M antigen which proved to be type 26 following serial mouse passage.
§ G indicates glossy, avirulent variant. li Previously this strain, which was derived from strain NY5 by animal passage, has been classified as type 10. Recently (22) it has been demonstrated that the M antigen of this strain is identical serologically with that of Griflith's original type 12 strain, S.F.42, although the two strains contain different T antigens. Since the M and not the T antigen is related to virulence and immunity, it has been customary in this laboratory to classify types according to the M antigen; therefore, strain E14/R31-27/O has been classified as type 12 to conform with the other types.
were made after incubation for 4 to 6 hours at 56°C. Controls consisted of at least one preinoculation monkey serum, aPlain broth control for the suspension, and a positive control of absorbed rabbit antisera of known antibody content. Suspensions of type 1 streptococd pre-viously digested with trypsin were usually used to detect the presence of non-type-specific agglutinins.
The details of the method for the bactcriostatic test have been previously described (31) . In the present study both the direct and indirect techniques were used. In the direct method, 0.25 cc. of fresh heparinizcd monkey blood was mixed with 0.05 cc. of tenfold serial culture dilutions varying from 10 -8 through I0 -s respectively in each of a series of tubes (7)< 100 ram.); in the indirect method, each tube contained 0.25 cc. of fresh hepafinizcd blood from afebrile children 13 to 9 years of age, 0.05 cc. of culture dilution, and 0.05 cc. of the monkey serum to be tested. The tubes were sealed with rubber stoppers and rotated in a mixing machine for 3 hours. At the end of this time a sample of the mixture was removed with a loop 3.0 ram. across and streaked evenly over a quadrant of a fresh 5 per cent rabbit blood agar plate, which was then incubated for 18 to 24 hours at 37°C. Growth was recorded as previously described (31) . Controls for the presence of bacteriostatic antibodies in the human blood, a preinoculation monkey serum, and 2 heterologous type strains for specificity were invariably included. The test was considered positive only if there was at least a twofold difference s in the growth from at least 2 dilutions as compared with the control.
Early in the course of this study it became apparent that following intranasal inoculation the monkeys showed no obvious clinical signs of illness, nor were their rectal temperatures, leucocyte counts, erythrocyte sedimentation rates, or body weights indicative of an infection. It was noted, however, that following intranasal inoculation with a matt (M-containing) strain, the same strain could usually be recovered on nasopharyngeal cultures for several weeks following the inoculation and the antistrcptolysin O content of the scra of these animals generally showed a significant increase in titre. Furthermore, those monkeys with negative antifibrinolysin tests prior to successful implantation usually showed increased resistance to lysis of their plasma clots 2 to 4 weeks following the successful inoculation. These 3 tests, therefore, indicated that the monkcy's nasopharynx not only offered a favorable medium for the implantation but also for the multiplication of group A streptococci.
In this study implantation was considered to have been successful if following the inoculation the same strain could be recovered in nasopharyngeal cultures for at least I week, and/or if the serum antistreptolysin O titre showed a significant increase. An increase in the antistreptolysin O titre was considered significant only if the titre following inoculation increased by 2 dilutions or more. Animals were considered to have had a de~_ite increase in the antifibrinolysin content of their blood only if there was an increase of at least two degrees of resistance to lysis of their plasma clots following inoculation.
EXPERIMENTAL RESULTS
In Table II s Growth on the blood agar plates was graded from 0 (no growth) to q --b -b~ (heavy growth). The test was considered positive then only if there was at least a ~-b difference in growth from at least 2 dilutions when compared with the control.
tures are reported as positive, the number of weeks that the inoculating strain could be recovered from the nasopharynx is also recorded.
It is apparent from Table II that the duration of the carrier state varied between 9 days (5th inoculation, monkey 13) and 28 weeks (lst inoculation, monkey 15), and that it was 5 weeks or more with only three exceptions. Where the results of the culture are recorded as negative, it was usually impossible to recover the same strain for more than 24 to 48 hours after inoculation. In other words, it appears that the animal either harbored the streptococci for several weeks to several months, or rapidly removed them from the site of the inoculation.
The antistreptolysin O titre before and the maximal titre reached after each inoculation are also recorded in Table II . The results of these tests show that in 31 or 83.8 per cent of the 37 instances in which the nasopharyngeal cultures were positive for at least 1 week following inoculation, there was also a significant increase in the antistreptolysin O titre. These results correspond with those found in human beings following proven group A streptococcal upper respiratory tract infections (32, 33) . It is also noteworthy that 4 out of the 6 failures to obtain a significant increase in the antistreptolysin O titre following a positive inoculation occurred after nasal instillation of the same strain, namely 1RS85. It is possible that this strain does not produce as much streptolysin O as the other strains employed. Another failure followed the instillation of strain J17F, type 26, which was used to test the resistance of monkey 36-88 following a positive inoculation with another type 26 strain, llRS50. In this case, strain J17F was recovered from the animal's nasopharynx for only 10 days following inoculation.
In general the antistreptolysin O curves following successful implantation were similar to those seen following uncomplicated group A streptococcal throat infections in man. The maximal titres occurred between the 2nd and 10th weeks following inoculation with the large majority reaching a maximum between the 3rd and 4th weeks. The highest titre observed was 1,000 units/cc. following inoculation of monkey 4-73 with strain T12/36/O; the preinoculation titre in this instance was 150 units/cc.
The antifibrinolysin tests recorded in Table II did not, in general, prove as useful in distinguishing between successful and unsuccessful implantations as the antistreptolysin O test for the following two reasons: First, because the test is not quantitative, and further increases in the resistance of plasma clots, which showed -4-+ + to + + + + resistance to lysis before inoculation cottld not be measured; second, plasmas from the same animal in some instances showed great variation in resistance to lysis from day to day. s Such variations make it s It may be significant that the antifibrinolysin test showed marked variability (from negative to + + + + ) in all 4 instances following inoculation with glossy strains. This marked variability was also noted in 2 animals following inoculation with matt strains. impossible to state whether the animal developed increased resistance of its plasma clot following inoculation; and where they occurred, the results are recorded as variable in Table II . Table II shows that 4 of the 13 animals exhibited maximal resistance to lysis of their plasma clots before their initial inoculations and, therefore, further increases in resistance to lysis could not be measured. Three other animals developed q-q-W-t-resistance to lysis of their plasma clots following their initial inoculations and maintained this degree of resistance throughout the period of study. In the 15 cases in which the antifibrinolysin test was nu~ or less before inoculation and in which the nasopharyngeal cultures became positive, 13 or 86.7 per cent developed significant increases in antifibrinolysin following inoculation. On the other hand, in only 1 of 7 instances or 14.3 per cent did a significant increase in resistance to lysis occur when the nasopharyngeal cultures were negative following the inoculation. From these data it is apparent that in those cases where inoculation was followed by a persistent carrier state for 1 week or longer and by a significant rise in the antistreptolysin O titre, the antifibrinolysin test also showed a significant increase in the resistance of the plasma clot to lysis when it could be measured. Table III summarizes all inoculations according to the strain and type employed either for primary inoculations or for reinoculations. Under primary inoculations are listed, according to the strain used, all initial inoculations made on animals with that particular type. 4 Under reinoculations are listed, according to the strain used, all second and/or third inoculations made on any one animal with that particular type. For example, 8 primary inoculations were made with strain 5RS101, type 32, which means that 8 different animals which had not previously been inoculated with a type 32 strain received this culture. Under the heading "reinoculations" the figures show that these 8 animals received'either strain 5RS101 or C51, both type 32, a second or third time, 4 to 19 months later.
Of the 38 primary inoculations, 31 or 81.6 per cent were positive by the criteria adopted. Since 4 out of the 7 which gave negative results followed intranasal instillation of glossy, avirulent strains (T12G or 24RS50G) it is found that 31 or 91.2 per cent of the 34 primary inoculations made with matt strains resuited in carrier states which persisted for 1 week or longer. On the other hand, when these animals were reinoculated 2 to 27 months later with strains of the same type, even though not with the same strain, only 8 or 28.6 per cent of the 28 reinoculations were positive. Furthermore, 5 of the 8 positive reinoeulations followed negative primary inoculations; 4 of these were made with glossy strains 4 The inoculations with strain T12/36/0 listed under primary inoculations are an exception to this statement as both of these animals had previously been inoculated with strain T12 glossy. In both instances, however, the inoculation with the T12 glossy strain failed to induce a carrier state or an antistreptolysin O response. and the fifth was made with a matt strain, C630, which failed to induce either a carrier state or an increase in the antistreptolysin O titre. When these 5 cases are eliminated, only 3 or 13.1 per cent of the 23 reinoculations were positive in the group of animals which had previously been successfully inoculated with the same matt type. That this resistance to reinoculation was type-specific is After finding that the monkeys were usually resistant to reimplantation with the same type of streptococci to which they had been previously susceptible, it became of interest to learn whether they developed type-specific circulating antibodies. The two tests selected for this purpose were the agglutination reaction and the bacteriostatic test. It should be recalled that we have already demonstrated that 83.8 per cent of the animals successfully implanted developed significant increases in the non-type-specific antibody, antistreptolysin O.
Summary of Results of Primary and Reinoculations
In Table IV are presented the results of agglutination tests made on sera of 11 monkeys following 20 different inoculations, together with such comparative data as success or failure of intranasal implantations and antistreptolysin O responses. In all 20 instances the homologous type matt strain and heterologous type controls were used; while in 15 the homologous type glossy strain was also included in the tests to learn whether the agglutinins were directed toward the T or M antigen or both. From this table it appears that 11 of the 14 successful inoculations were followed by antibody responses to the homologous type matt strain as determined by the agglutinin test; but following 5 of these 11 inoculations, non-specific agglutinins also appeared or increased in titre if present before the particular inoculation. In every case, however, the fitre developed to the homologous type matt strain was greater than that to the heterologous type; and in 6 instances no agglutinins were demonstrable to the heterologous type. In contrast it should be noted that none of the 6 animals unsuccessfully inoculated developed type-specific agglutinins in their sera to the homologous matt strain which had been instilled intranasally.
When the results of the agglutinin tests with homologous type glossy strains are considered, it is evident that the titre increased following 7 of 15 inoculations. Further analysis of these 7 cases shows that not only did the sera of all 7 animals have agglutinins to the glossy strain prior to the inoculation, but that in 2 animals the agglutinins increased after an unsuccessful inoculation, and in one other the antibody increased following inoculation with strain C630 (type 14) which did not contain the respective T antigen. In view of these findings and of the fact that glossy strains are more sensitive to non-specific agglutination than are matt strains, it is impossible to attribute the increased agglutination of the glossy strains to antibodies directed toward their T antigens. On the other hand, type-specific agglutinins with respect to the M antigens could be demonstrated in the sera of most of the animals following successful inoculation. * Strains 11RS50 and 24RS50G contain a common agglutinogen which is neither the M or T antigen. 11RS50 wasobtainedfromapatientwithacuteptmryngitiswhichwasfolluwedbyanattackof rheumatic fever. 24RSSOG was isolated from the same patient 41 months later during convalescence from attack of rheumatic fever. Strain 24RSSOG recovered its capacity to produce the M antigen which proved to belong to type 26 following serial animal passage.
The figure represents the highest serum dilution in which there was definite agglutination. All figures are final dilutions.
§ G indicates glossy, aviraleut variant.
Tests were made for the presence of bacteriostatic antibodies before and after 13 inoculations on 12 different animals. There was successful implantation of the streptococci for 1 week or more following all of these inoculations but in only 6 instances was there a significant increase in the antistreptolysin O titres.
Four of the bacteriostatic tests were done by the direct method; in the remaining 9 the indirect technique was used. Two of the 4 tests made by the direct method were positive; that is, following these 4 inoculations, 2 animals developed definite bacteriostatic antibodies for the strains used for the inoculation and not for heterologous type control strains. By the indirect method, bacteriostatic antibodies were demonstrated following only 2 of 9 inoculations. It is noteworthy that in 6 of these instances there was also a failure on the part of the animal to develop significant antistreptolysin O in its serum following the inoculation. Although the number of animals (4 of 13 inoculations) which developed demonstrable bacteriostatic antibodies is small, it is significant that these few developed circulating antibodies which were definitely type-specific.
Blood cultures taken at 5 and 24 hour intervals following successful intranasal inoculation of 3 animals with strain llRS50 (type 26) and 2 others with strain 5RS101 (type 32) revealed no growth of group A streptococci. At the end of the period of observation complete autopsies were performed on all but 2 of the animals (monkeys 13 and 18), and none showed lesions on either macroscopic or microscopic examination suggestive of previous streptococcal infections or sequelae. Also cultures of the deep cervical lymph nodes from 4 of the animals were negative for group A streptococci.
DISCUSSION
In this study we have demonstrated that most of the Macaca mulat~a inoculated intranasally with matt strains of group A streptococci became carriers of these strains for several weeks to several months following inoculation. Furthermore, when such a successful inoculation with a particular type of group A streptococcus occurred, the animal usually resisted reimplantation with that same type for several months and sometimes for a year or more, although implantation with a heterologous type could generally be easily effected. This resistance has been shown to be closely correlated with the type-specific M antigen and not with the T antigen of the strains employed. In addition, a majority of the animals in which implantation was successful developed significant increases in their serum antistreptolysin O titers; and in a limited number of instances in which the tests were made, type-specific agglutinins and bacteriostatic antibodies were also demonstrable in the animals' sera following successful intranasal implantation. On the other hand, after intranasal inoculation with glossy, avirulent strains, carrier states could not be induced; these animals, moreover failed to show antibody responses and were susceptible to implantation with the matt variants of the homologous glossy types when tested a few months later.
From these results it would appear that matt strains of group A streptococci are adapted not only for implantation but also for multiplication in the nasopharynx of Macaca mulatta. Thus far we have avoided applying the term "infected" to those animals in which the streptococci were successfully implanted and which subsequently developed circulating antibody responses. Strictly speaking, we believe the term infection implies not only multiplication of the infective agent but also invasion of the host's tissues. As stated previously, none of the animals appeared sick following inoculation; and the white blood cell count, erythrocyte sedimentation rate, temperature and weight curves were of no value in determining whether implantation had occurred. Although we have no definite proof that successful implantation was accompanied by invasion of the animal's tissues, it appears unlikely that the streptococci merely colonized on the surface of the monkey's nasopharyngeal mucosa, and we, therefore, believe that these animals most likely suffered subclinical infections.
Many workers have demonstrated antibodies to various toxins and to a wide variety of bacteria and viruses in human beings as well as in lower animals with no history or obvious signs of previous infections or of contacts with the agents. Needless to say, much discussion has arisen as to the stimulus responsible for the production of these antibodies; whether the antibodies are so called natural antibodies or whether they have developed in response to contact or subclinical infection with the agent toward which they are directed or toward other antigens containing similar haptogenic chemical groups. Although the data presented in this communication do not contribute directly toward the solution of this question, they do indicate that an anlmal may develop specific antibodies to bacterial antigens without manifesting any demonstrable signs or symptoms Of infection.
In this connection it is of interest that Kuttner (34) found, in a series of 38 children who suffered dear-cut rheumatic recurrences, that 19 or 50 per cent had either no signs or symptoms of the preceding streptococcal infection or the signs and symptoms were so slight that they were detected only because the patients were in an institution where the temperature was checked three times a day and throat cultures were taken as routine every week, or more often when indicated. It is significant, however, that 15 or 79 per cent of these 19 children developed a rise in their antistreptolysin O titers following the appearance of streptococci in their throats. Our own observations (35) on a group of rheumatic subjects are in accord with these findings. More recently the U. S. Army Commission on Acute Respiratory Diseases (36) found significant increases in the antistreptolysin O titres or the antifibrinolysin test in nearly half of the "healthy" carriers of group A type 5 streptococci following an explosive epidemic of septic sore throats in troops; and expressed the opinion that a proportion of these carriers were subclinical cases. It is aho of interest that only those carriers who harbored the streptococci for 10 days or more exhibited antibody responses.
The results of the experiments with monkeys are in agreement with informa-tion previously gained regarding immunity to group A streptococcal infections in rodents; that is, immunity is type-specific with respect to the M content of group A streptococci in that this immunity or protection is due to the antibody directed toward the type-specific M and not toward the T antigen. Also the results are in accord with the known information regarding immunity to group A streptococcal infections in man. As previously mentioned, not a single case has been reported in which it has been shown that a patient suffered two separate respiratory tract infections with the same type of streptococcus. It is well established, on the other hand, that many of the late purulent complications and almost invariably the relapses and recurrent sore throats occurring in scarlet fever patients are due to types of streptococci other than those which caused the original scarlatinal infection. Although autogenous reinfections of other parts of the body do occasionally occur with the same type of streptococcus which had previously caused a nasopharyngeal infection, it seems likely that in these cases the site of infection was particularly susceptible to invasion, as in the case of the parturient uterus, or that the dose of the infecting microorganisms was overwhelming, or that both conditions prevailed. It is also possible, even probable, that certain individuals are poor antibody producers and that certain types of streptococci are poor antigens in so far as the typespecific M antigen is concerned. We have recently been able to show with the bacteriostatic test that following nasopharyngeal infections with group A streptococci the majority of human beings develop circulating type-specific antibodies, which, in certain instances, have been demonstrable for periods as long as 12 to 24 months following the infections (37) . These observations, correlated with the present data from monkey inoculations and with previous studies on rodents, make it appear likely that man usually develops some degree of type-specific resistance following group A streptococcal infections. One cannot state at present the duration of such a type-specific immunity in man. Doubtless the probability of a second infection with a given type will depend on several factors: the size of the reinfecting dose; the site and condition of the reinfected tissues; and the degree of immunity remaining from the previous infection.
Even though these factors cannot be accurately appraised, it is now evident that' patients with group A streptococcal infections, such as scarlet fever or tonsillitis, even though exhibiting similar clinical signs and symptoms, should be considered as potential sources of danger, one to the other, unless it can be established that contiguous patients have the same type of streptococci causing their: respective infection. In o[her words, from the standpoint of isolation, patients infected with different types of group A streptococci should be as carefully isolated as though they were suffering from different infectious diseases.
S U~r~y AND CONCLUSIONS 1. Nasopharyngeal carrier states of several weeks to several months duration were induced in the Macaca mula#a by the intranasal inoculation with matt strains of group A streptococci.
2. Following such a successful inoculation with a particular type of group A streptococcus, the animal was usually resistant to reimplantation with that same type for several months to a year or more, although reimplantation with a heterologous type could generally be easily effected.
3. This resistance was shown to be closely correlated with the antibodies directed toward the type-specific M antigen, not toward the T antigen of the strains employed.
4. A majority (83.8 per cent) of the animals in which intranasal inoculation was followed by successful implantation developed significant increases in the antistreptolysin O titres of their sera; and in a limited number of instances, type-specific agglutinins and bacteriostatic antibodies were demonstrable in the animals' sera following successful implantation.
5. Nasopharyngeal carrier states could not be induced with the glossy, avirulent variants of group A streptococci; these animals, moreover, failed to show antibody responses and were susceptible to implantation with the matt variants of the homologous glossy strains.
6. The findings are in accord with the known facts regarding immunity to group A streptococci gained through experiments on rodents; and the possible relationship of these observations to the problem of type-specific immunity ill human beings is discussed.
